Quick Answer
ABEONA THERAPEUTICS INC. reported Total Assets of $219.57 million for the year ending 2025.
- ABEONA THERAPEUTICS INC. showed an increase of +101.6% in Total Assets from 2024 to 2025.
- This data is from ABEONA THERAPEUTICS INC.'s annual report (Form 10-K), filed with the SEC on March 17, 2026.
- XBRL data for this metric is available from 2010 to 2025 (16 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q2 2011: $5.07 million | Q3 2011: $2.22 million | Q1 2012: $3.20 million | Q2 2012: $2.44 million | Q3 2012: $1.23 million | Q1 2013: $1.72 million | Q2 2013: $2.40 million | Q3 2013: $1.09 million | Q1 2014: $478.0 thousand | Q2 2014: $240.0 thousand | Q3 2014: $280.0 thousand | Q1 2015: $13.12 million | Q3 2015: $89.55 million | Q1 2016: $77.42 million | Q2 2016: $74.15 million | Q3 2016: $73.81 million | Q1 2017: $105.28 million | Q2 2017: $96.66 million | Q3 2017: $95.73 million | Q1 2018: $175.65 million | Q2 2018: $166.70 million | Q3 2018: $160.58 million | Q1 2019: $166.14 million | Q2 2019: $159.41 million | Q3 2019: $142.77 million | Q1 2020: $175.00 million | Q2 2020: $164.38 million | Q3 2020: $159.37 million | Q1 2021: $141.43 million | Q2 2021: $130.68 million | Q3 2021: $119.02 million | Q1 2022: $55.17 million | Q2 2022: $44.72 million | Q3 2022: $38.76 million | Q1 2023: $53.35 million | Q2 2023: $53.55 million | Q3 2023: $66.09 million | Q1 2024: $74.83 million | Q2 2024: $134.00 million | Q3 2024: $120.59 million | Q1 2025: $99.36 million | Q2 2025: $246.23 million | Q3 2025: $231.10 million.
- Over the full 16 years of available data (2010 to 2025), ABEONA THERAPEUTICS INC.'s Total Assets has grown by 2,403.4%.
- Historical annual values: Fiscal year 2025: $219.57 million | Fiscal year 2024: $108.93 million | Fiscal year 2023: $64.00 million | Fiscal year 2022: $64.21 million | Fiscal year 2021: $79.59 million | Fiscal year 2020: $151.20 million | Fiscal year 2019: $223.38 million | Fiscal year 2018: $174.40 million | Fiscal year 2017: $178.77 million | Fiscal year 2016: $111.06 million | Fiscal year 2015: $80.06 million | Fiscal year 2014: $16.58 million | Fiscal year 2013: $613.0 thousand | Fiscal year 2012: $1.73 million | Fiscal year 2011: $3.79 million | Fiscal year 2010: $8.77 million.
- Data sourced from SEC EDGAR public filings as of August 6, 2026.
Last verified: